| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Hong R, Perkins M, Gabbe BJ, Tracy LM. Comparing Peak Burn Injury Times and Characteristics in Australia and New Zealand. International Journal of Environmental Research and Public Health. 19. PMID 35954935 DOI: 10.3390/ijerph19159578 |
0.01 |
|
| 2022 |
Putnam EM, Hong RA, Park JM, Li Y, Leis A, Malviya S. Intravenous ondansetron reduced nausea but not pruritus following intrathecal morphine in children: interim results of a randomized, double-blinded placebo-control trial. Paediatric Anaesthesia. PMID 35778960 DOI: 10.1111/pan.14517 |
0.01 |
|
| 2022 |
Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Wah Lai K, Liu W, Ma S, et al. Structure-based Optimization of Hydroxylactam as Potent, Cell-Active Inhibitors of Lactate Dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 128576. PMID 35065235 DOI: 10.1016/j.bmcl.2022.128576 |
0.01 |
|
| 2021 |
Li Y, Swallow J, Robbins C, Caird MS, Leis A, Hong RA. Gabapentin and intrathecal morphine combination therapy results in decreased oral narcotic use and more consistent pain scores after posterior spinal fusion for adolescent idiopathic scoliosis. Journal of Orthopaedic Surgery and Research. 16: 672. PMID 34781972 DOI: 10.1186/s13018-021-02525-z |
0.01 |
|
| 2021 |
Song KW, Edgar KA, Hanan EJ, Hafner M, Oeh J, Merchant M, Sampath D, Nannini MA, Hong R, Phu L, Forrest WF, Stawiski E, Schmidt S, Endres N, Guan J, et al. RTK-dependent inducible degradation of mutant PI3Kα drives GDC-0077 (Inavolisib) efficacy. Cancer Discovery. PMID 34544753 DOI: 10.1158/2159-8290.CD-21-0072 |
0.01 |
|
| 2018 |
Daemen A, Liu B, Song K, Kwong M, Gao M, Hong R, Nannini M, Peterson D, Liederer BM, de la Cruz C, Sangaraju D, Jaochico A, Zhao X, Sandoval W, Hunsaker T, et al. Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. Cell Metabolism. PMID 30043751 DOI: 10.1016/J.Cmet.2018.06.003 |
0.01 |
|
| 2017 |
Li Y, Hong RA, Robbins CB, Gibbons KM, Holman AE, Caird MS, Farley FA, Abbott MD, Burke MC. Intrathecal Morphine and Oral Analgesics Provide Safe and Effective Pain Control after Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis. Spine. PMID 28538591 DOI: 10.1097/BRS.0000000000002245 |
0.01 |
|
| 2017 |
Lau J, Cheung J, Navarro A, Lianoglou S, Haley B, Totpal K, Sanders L, Koeppen H, Caplazi P, McBride J, Chiu H, Hong R, Grogan J, Javinal V, Yauch R, et al. Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice. Nature Communications. 8: 14572. PMID 28220772 DOI: 10.1038/Ncomms14572 |
0.01 |
|
| 2017 |
Edgar K, Hanan E, Staben S, Schmidt S, Hong R, Song K, Young A, Hamilton P, Arrazate A, Cruz Cdl, Belvin M, Nannini M, Friedman LS, Sampath D. Abstract 156: Preclinical characterization of GDC-0077, a specific PI3K alpha inhibitor in early clinical development Cancer Research. 77: 156-156. DOI: 10.1158/1538-7445.Am2017-156 |
0.01 |
|
| 2017 |
Song KW, Edgar KA, Kirkpatrick DS, Phu L, Schmidt S, Nannini M, Hong R, Cheng E, Crocker L, Young A, Sampath D, Friedman L. Abstract 146: The PI3K inhibitor, taselisib, has a unique mechanism of action that leads to enhanced potency in PIK3CA mutant models Cancer Research. 77: 146-146. DOI: 10.1158/1538-7445.Am2017-146 |
0.01 |
|
| 2016 |
Hong RA, Gibbons KM, Li GY, Holman A, Voepel-Lewis T. A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis. Paediatric Anaesthesia. PMID 27878902 DOI: 10.1111/Pan.13037 |
0.01 |
|
| 2016 |
Boudreau A, Purkey HE, Hitz A, Robarge K, Peterson D, Labadie S, Kwong M, Hong R, Gao M, Del Nagro C, Pusapati R, Ma S, Salphati L, Pang J, Zhou A, et al. Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nature Chemical Biology. PMID 27479743 DOI: 10.1038/Nchembio.2143 |
0.01 |
|
| 2016 |
Ebert PJ, Cheung J, Yang Y, McNamara E, Hong R, Moskalenko M, Gould SE, Maecker H, Irving BA, Kim JM, Belvin M, Mellman I. MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade. Immunity. PMID 26944201 DOI: 10.1016/J.Immuni.2016.01.024 |
0.01 |
|
| 2016 |
Friedman L, Edgar K, Song K, Schmidt S, Kirkpatrick D, Phu L, Nannini M, Hong R, Cheng E, Crocker L, Young A, Sampath D. Abstract S6-04: The PI3K inhibitor, taselisib, has enhanced potency in PIK3CA mutant models through a unique mechanism of action Cancer Research. 77: 370-370. DOI: 10.1158/1538-7445.Sabcs16-S6-04 |
0.01 |
|
| 2015 |
Daemen A, Peterson D, Sahu N, McCord R, Du X, Liu B, Kowanetz K, Hong R, Moffat J, Gao M, Boudreau A, Mroue R, Corson L, O'Brien T, Qing J, et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 112: E4410-7. PMID 26216984 DOI: 10.1073/Pnas.1501605112 |
0.01 |
|
| 2015 |
Hong R, Gauger V, Caird MS, Burke C. Narcotic-only Epidural Infusion for Posterior Spinal Fusion Patients: A Single-Center, Retrospective Review. Journal of Pediatric Orthopedics. PMID 25887830 DOI: 10.1097/BPO.0000000000000490 |
0.01 |
|
| 2015 |
Daemen A, Peterson D, Sahu N, McCord R, Du X, Liu B, Kowanetz K, Hong R, Moffat J, Gao M, Boudreau A, Mroue R, Corson L, O'Brien T, Qing J, et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors Proceedings of the National Academy of Sciences of the United States of America. 112: E4410-E4417. DOI: 10.1073/pnas.1501605112 |
0.01 |
|
| 2014 |
O'Brien T, Purkey H, Hitz A, Peterson D, Boudreau A, Delnagro C, Kwong M, Hong R, Gao M, Pang J, Vanderbilt A, Williams S, Salphati L, Sampath D, Hatzivassiliou G, et al. Abstract 964: Inhibiting glycolysis with an LDHA inhibitor: A new solution to an old problem Cancer Research. 74: 964-964. DOI: 10.1158/1538-7445.Am2014-964 |
0.01 |
|
| 2013 |
Tan N, Wong M, Nannini MA, Hong R, Lee LB, Price S, Williams K, Savy PP, Yue P, Sampath D, Settleman J, Fairbrother WJ, Belmont LD. Bcl-2/Bcl-xL inhibition increases the efficacy of MEK inhibition alone and in combination with PI3 kinase inhibition in lung and pancreatic tumor models. Molecular Cancer Therapeutics. 12: 853-64. PMID 23475955 DOI: 10.1158/1535-7163.Mct-12-0949 |
0.01 |
|
| 2013 |
Lin J, Sampath D, Nannini MA, Lee BB, Degtyarev M, Oeh J, Savage H, Guan Z, Hong R, Kassees R, Lee LB, Risom T, Gross S, Liederer BM, Koeppen H, et al. Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1760-72. PMID 23287563 DOI: 10.1158/1078-0432.Ccr-12-3072 |
0.01 |
|
| 2013 |
Liu B, Song K, Kwong M, Gao M, Hong R, Nannini M, Sampath D, Belvin M, Peterson D, Evangelista M, Daemen A, Firestein R, Hatzivassiliou G. Abstract 4618: Elucidating the role of distinct glutaminase isoforms in cancer. Cancer Research. 73: 4618-4618. DOI: 10.1158/1538-7445.Am2013-4618 |
0.01 |
|
| Hide low-probability matches. |